ArticleFrontiers in immunology2019

Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes.

Thomas Barba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.